Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

US Patent 5879657 · Granted Mar 9, 1999

Estimated economic value: $62,327,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-target crosslinkers and uses thereof2025
Micromolecular type III collagen peptide capable of promoting secretion of type 2025
Folding fan2025
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Method for treatment of a viral-mediated infectious disease2025
Methods of treating chemotherapy induced neutropenia using fixed doses of eflape2024
Method for preparing active protein peptide and prepared active protein peptide 2024
Underwater cleaner2024
Method for preparing protein peptide based on connective tissue and prepared pro2024
Polymer conjugated thyrointegrin antagonists2023
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof2023
Inhibitors of integrin alpha 2 beta 1 and methods of use2023